Cancers of anal canal: A review article

Asheesh Kumar Gupta, Ashish Kumar Gupta, Achal Gupta, Akshara Gupta, Arun Kumar Pargi, Rahul Dubepuria


Malignant tumours of the anal canal are rare and diverse group of tumours of gastrointestinal tract and comprises of 2.5 percent of all digestive system malignancy in United States. Although incidence rates are still low, there has been a significant increase in squamous cell carcinoma over the last 50 years. HIV infected homosexual men appear particularly at risk. HPV DNA is detectable in most anal squamous cell carcinomas. Despite its short length, the anal canal produces a variety of tumour type’s reflecting its complex anatomic and histological structure. Squamous, glandular, transitional, and melanocytic components occur at this site, either alone, or in combination. Due to the paucity of this malignancy it has been difficult to establish generally accepted guidelines for treatment. While for some neoplasms, the treatment of choice is clear-cut, for others it is still controversial. This review article makes an attempt to clarify current clinical, pathological and therapeutic options for anal canal tumors in the light of recent information.


Abdominoperineal Ressection, anal canal carcinoma, squamous cell carcinoma, human papilloma virus

Full Text:



Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.

Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: The surveillance, epidemiology, and end results experience, 1973- 2000. Cancer 2004;101:281-8.

Palefsky JM. Anal human papillomavirus infection and anal cancer in HIV-positive individuals: An emerging problem. AIDS 1994;8:283-95.

Myerson RJ, Karnell LH, Menck HR. The national cancer data base report on carcinoma of the anus. Cancer 1997;80:805-15.

Klotz RG Jr, Pamukcoglu T, Souilliard DH. Transitional cloacogenic carcinoma of the anal canal. Clinicopathologic study of three hundred seventy-three cases. Cancer


Cummings BJ. Current management of epidermoid carcinoma of the anal canal. Gastroenterol Clin North Am 1987;16:125-42.

Beck D, Wexner S. Anal neoplasms. In: Beck D, Wexner S, editors. Fundamental of Anorectal Surgery. New York: Mc Graw-Hill; 1992. p. 222-237.

Hermanek P, Sobin L. International Union against cancer. TNM Classifi cation of Malignant Tumors. 4th ed. New York: Springer – Verlag; 1987. p. 50-2, 83-8.

Klas JV, Rothenberger DA, Wong WD, Madoff RD. Malignant tumors of the anal canal: The spectrum of disease, treatment, and outcomes. Cancer 1999;85:1686-93.

Goligher JC, Leacock AG, Brossy JJ. The surgical anatomy of the anal canal. Br J Surg 1955;43:51-61.

Scholefi eld JH, Kerr IB, Shepherd NA, Miller KJ, Bloomfi eld R, Northover JM. Human papillomavirus type 16 DNA in anal cancers from six different countries. Gut 1991;32:674-6.

Palefsky J, Gonzales J, Greenblatt R, et al. HPV-associated anogenital neoplasia and other solid tumors in HIV infected individuals. Curr Opin Oncol 1991;3:881-5.

Zaki SR, Judd R, Coffi eld LM, Greer P, Rolston F, Evatt BL. Human papillomavirus infection and anal carcinoma. Retrospective analysis by in situ hybridization and the polymerase chain reaction. Am J Pathol 1992;140:1345-55.

Northfelt DW, Swift PS, Palefsky JM. Anal neoplasia. Pathogenesis, diagnosis, and management. Hematol Oncol Clin North Am 1996;10:1177-87.

Cleary RK, Schaldenbrand JD, Fowler JJ, Schuler JM, Lampman RM. Perianal Bowen’s disease and anal intraepithelial neoplasia: Review of the literature. Dis Colon Rectum 1999;42:945-51.

Surawicz C, Kiviat N. A rational approach to anal intraepithelial neoplasia. Semin Colon Rectal Surg 1998;9:99-106.

Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000;342:792-800.

Stephenson J. Health agencies update: Anal cancer screening JAMA 2000;283:3060.

Frisch M, Glimelius B, Wohlfahrt J, Adami HO, Melbye M. Tobacco smoking as a risk factor in anal carcinoma: An antiestrogenic mechanism? J Natl Cancer Inst 1999;91:708-15.

Cummings BJ. Anal cancer. In: Perez CA, Brady LJ, editors. Principles and Practice of Radiation Oncology. 3rd ed. Philadelphia: Lippincott-Raven; 1998. p. 1511-24.

Golden GT, Horsley JS 3rd. Surgical management of epidermoid carcinoma of the anus. Am J Surg 1976;131:275-80.

Minsky BD, Hoffman JP, Kelsen DP. Cancer of the anal region. In: De Vita Jr VT, Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology. 6th ed. Philadelphia: Lippincott-Williams and Wilkins; 2001. p. 1319-42.

Laish-Vaturi A, Gutman H. Cancer of the anus (review). Oncol Rep 1998;5:1525-9.

Roseau G, Palazzo L, Colardelle P, Chaussade S, Couturier D, Paolaggi JA. Endoscopic ultrasonography in the staging and follow-up of epidermoid carcinoma of the anal canal. Gastrointest Endosc 1994;40:447-50.

Beahrs OH, Wilson SM. Carcinoma of the anus. Ann Surg 1976;184:422-8.

Garofalo M Jr, Martin CA, Eng TT, Donnenfeld H, Smith FB, Masdeu JC. Neurologic complications of cloacogenic carcinoma. Am J Gastroenterol 1990;85:1189-91.

Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: A preliminary report. Dis ColonRectum 1974;17:354-6.

Nigro ND, Seydel HG, Considine B, Vaitkevicius VK, Leichman L, Kinzie JJ. Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 1983;51:1826-9.

Cummings BJ. Concomitant radiotherapy and chemotherapy for anal cancer. Semin Oncol 1992;19:102-8.

Papillon J, Montbarbon JF. Epidermoid carcinoma of the anal canal. A series of 276 cases. Dis Colon Rectum 1987;30:324-33.

Cho CC, Taylor CW 3rd, Padmanabhan A, Arnold MW, Aguilar PS, Meesig DM, et al. Squamous-cell carcinoma of the anal canal: Management with combined chemo-radiation therapy. Dis Colon Rectum 1991;34:675-8.

Goldman S, Glimelius B, Glas U, Lundell G, Påhlman L, Ståhle E. Management of anal epidermoid carcinoma – an evaluation of treatment results in two population-based series. Int J Colorectal Dis 1989;4:234-43.

Tanum G, Tveit KM, Karlsen KO. Chemoradiotherapy of anal carcinoma: Tumour response and acute toxicity. Oncology 1993;50:14-7.

Pyper PC, Parks TG. The results of surgery for epidermoid carcinoma of the anus. Br J Surg 1985;72:712-4.

Merlini M, Eckert P. Malignant tumors of the anus. A study of 106 cases. Am J Surg 1985;150:370-2.

Greenall MJ, Magill GB, Quan SH, DeCosse JJ. Recurrent epidermoid cancer of the anus. Cancer 1986;57:1437-41.

Cooper PH, Mills SE, Allen MS Jr. Malignant melanoma of the anus: Report of 12 patients and analysis of 255 additional cases. Dis Colon Rectum 1982;25:693-703.

Ward MW, Romano G, Nicholls RJ. The surgical treatment of anorectal malignant melanoma. Br J Surg 1986;73:68-9.

Wanebo HJ, Woodruff JM, Farr GH, Quan SH. Anorectal melanoma. Cancer 1981;47:1891-900.

Bolivar JC, Harris JW, Branch W, Sherman RT. Melanoma of the anorectal region. Surg Gynecol Obstet 1982;154:337-41.

Slater G, Greenstein A, Aufses AH Jr. Anal carcinoma in patients with Crohn’s disease. Ann Surg 1984;199:348-50.

Lee SH, Zucker M, Sato T. Primary adenocarcinoma of an anal gland with secondary perianal fi stulas. Hum Pathol 1981;12:1034-7.

Gordon PH. Current status – Perianal and anal canal neoplasms. Dis Colon Rectum 1990;33:799-808.

Molnár L, Bezsnyák I, Daubner K, Horák E, Svastits E. Anorectal sarcomas. Acta Chir Hung 1985;26:85-91.

Cummings BJ, Keane TJ, O’sullivan B, Wong CS, Catton CN. Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fl uorouracil with and without mitomycin c. Int J Radiat Oncol Biol Phys 1991;21:1115-25.

Pocard M, Tiret E, Nugent K, Dehni N, Parc R. Results of salvage abdominoperineal resection for anal cancer after radiotherapy. Dis Colon Rectum 1998;41:1488-93.

Allal AS, Laurencet FM, Reymond MA, Kurtz JM, Marti MC. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment. Cancer 1999;86:405-9.

Ajani JA, Carrasco CH, Jackson DE, Wallace S. Combination of cisplatin plus fl uoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal. Am J Med


Mahjoubi M, Sadek H, Francois E, et al. Epidermoid anal canal carcinoma (EACC): Activity of cisplatin (P) and continuous 5-fl uorouracil (5-FU) in metastatic (M) and/or local recurrent (LR) disease. Proc Am Soc Clin Oncol 1990;9:114a.

Palefsky JM, Holly EA, Hogeboom CJ, Berry JM, Jay N, Darragh TM. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:415-22.

Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. The clinical effectiveness and cost effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999;281:1822-9.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright © 2014 International Journal of Medical Science Research and Practice. All rights reserved. Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.